Start-up Innovation Challenge

Start-up Innovation Challenge

The most exciting innovations are coming from small start-ups who are largely unknown to the wider industry.

We are giving a handful of start-ups the chance to share their research and pitch their latest innovations live at Hi Europe & Ni. Our panel of industry judges will then select the company with the most exciting idea as winner of the Start-up Innovation Challenge. There wil be a contest winner and 'Natural Ingredient' special prize winner, awarded by Naturex.

Join us at the Industry Insight Theatre on the afternoon of 29 November to meet these true innovators of the industry.

In association with Agroparc and Presans
Supported by Naturex

Start Up Innovation Challenge
SCIADONICS

1. Sciandonics

Main activity

Anti-inflammatory conifer-derived lipids

Presentation

SCIADONICS was established in 2016 to commercialize SCI/related fatty acids to combat chronic inflammation epidemic. Lack of a commercially-viable seed source of SCI has blocked commercialization for many years. Their team of innovative thinkers has accomplished this important milestone. SCIADONICS Inc. is a Minnesota corporation formed September 2016, with a Norwegian holding company (Sciadonic AS).

They have developed new-to-the-market, proprietary fatty acid ingredients, with unique sourcing. The anti-inflammatory fatty acids have been lost to industrialization, but are used in Traditional Chinese Medicine and ethnic populations, and can be combined with other ingredients including fish oil. Their product offerings represent an innovative technology and a game changer in the anti-inflammatory oil space. Sources of their fatty acids, and mixtures thereof, are protected by four patent applications, one granted patent (Aug. 2016).

They are now seeking investors to meet milestones on regulatory GRAS/IND, industrial oil scale up, commercialization.

Leadership team

  • Alvin BERGER, CEO – Scientific Expertise

• Discoveries in lipid research. Academic/industrial expert on lipids including marine-, animal-, &
plant fatty acids, phospholipids, sphingolipids, gangliosides, plant sterols. Publications on
carbohydrates, proteins, antioxidants
• Experience with various health and disease states (heart, cognition, skin, bone, diabetes,
autoimmunity, inflammation).
• Numerous scientific papers, reviews, white papers, patents
• Editor of scientific journals

Prolupin

2. Prolupin

Main activity

PROLUPIN is a producer of high quality, lupine based plant proteins. They are creating value in
the complete supply-chain, from the farmer to the consumer, through their patented extraction
process and their own B2C food portfolio and B2B business partners.
In contrary to other plant based proteins, their lupine protein-isolate - awarded by The Federal
Presidents Award for Innovation and Technology 2014 - enables a sensory neutral product
profile, unmatched by any other plant protein based food/beverage offer.

Presentation

Their Vision
« We enable tasty vegan products for the mass market from a sustainable and regional protein
source. We want to contribute to a more sustainable living. That’s why we focus on producing
and offering the world’s top high-value plant proteins. »
 

Their Mission
« We want to inspire all of us to enhance the health of people and the planet by providing best
plant-based protein alternatives. Our local sourceable plant-based protein alternatives ignite the
acceptance and usage around the world. Without any compromise on your sensorial
requirements due to replacing animal protein. »
MADE WITH LUVE is their umbrella brand for a product range plant-based, vegan, free from
GMO, Lactose, Cholesterol and Gluten* (*except pasta).

Leadership team

  • Stampe MALTE, CEO
GREENFOOD 50

3. Greenfood 50

Main activity

GreenFood50 develops, manufactures and sells ingredients based on saponin-free quinoa. The
company works closely with Wageningen UR and other leading international organizations.
GreenFood50’s quinoa ingredients are rich in protein, dietary fiber and Omega 6/9 fatty acid, and
are gluten-free. These ingredients increase the nutritional value of the products they are
incorporated in and fit in with the current ‘free from’ trend.
These quinoa ingredients are applied in bakery products, salads, pastas, sauces, beverages, sports
nutrition, healthy bars, snacks, vegetarian and gluten free products.
GreenFood50 is a dynamic fast growing company.

Presentation

In co-operation with Wageningen University & Research, GreenFood50 has developed a
comprehensive range of quinoa ingredients: Quinoa seeds, Quinoa flours, Quinoa puffs
Quinoa crisps, Quinoa flakes, Quinoa precooked, Quinoa proteins, Quinoa starches, Quinoa
fibers.
GreenFood50 quinoa ingredients have unique benefits:

  • • Excellent taste and smell
  • • Highly nutritious with proteins, dietary fibres, omega-6/9 fatty acids, vitamins & minerals
  • • Gluten-free
  • • Low glycemic index
  • • No additives and no preservatives
  • • Sustainable EU production.

Leadership team

  • Marc ARTS, CEO
pervida

4. Pervida

Main acitivy

PERVIDA is a division of Biotherapeutics Inc. Biotherapeutics develops safer and more effective nutritionals and therapeutics for autoimmune and metabolic diseases.

Presentation

Pervida™ develops products containing scientifically sound natural ingredients. Through focused execution, innovative proprietary technology with strong IP, and committed leadership, Pervida™ connects science and healthy lifestyles. Pervida™ is anchored on innovation, naturally occurring products, scientifically proven health benefits, the highest safety standards, and quality control to generate foods and beverages that improve health and well-being.

  • Technology platform: Pervida™ brand includes health water for glycemic control (ABA) and digestive and immune health (PUA).
  • Validation: Strong preclinical data and favorable safety profile in 6 animal, in vitro, and in silico models, plus human proof-of-concept data for ABA.
  • IP Protection: 9 US patents filed and 5 USPT issued
  • Product Development plan: The Pervida™ brand will launch two products in 2017: Pervida™ Immune health water with PUA and Pervida™ Sugar Control health water with ABA
  • Regulatory Standards: The ingredients are natural and have Generally Regarded as Safe (GRAS) status.
  • Financing: seeking financial support to advance Pervida Immune health water for gut and immune health to market and to advance Pervida Sugar Control health water for glucose control.

Leadership team

  • Josep BASSAGANYA- RIERA, President and CEO
  • Adria CARBO, Chief Operating Officer
  • Sandra EINERHAND, PHD, Global Head BTI Nutritionals
Bayn

5. Bayn

Main activity

Sugar Reduction

Presentation

Bayn Europe is a knowledge company helping food producers around the world to meet market demands in building a healthier world. Bayn’s solutions reduce sugar in products, creating new, naturally sweetened low calorie diets. Their natural ingredients, refined through scientific research, are developed into innovative, healthy recipes in close partnership with our customers in the global food and beverage industry.

Bayn is at the forefront of sugar reduction research in food, cooperating with leading food research institutes and scientists all over the world. The R&D team at Bayn works in close cooperation with the manufacturing partners and external institutes creating a broad research and development platform. Research in industrial solutions, quality testing methods, plant yield improvements and refining technology contributes to the advantages of Bayn’s products.

Leadership team

  • Lucy DAHLGREN, Managing Director
ideas 2 launch

6. Ideas 2 launch

Main activity

The company has launched in 2015 a range of Ready to drink Tea beverages made from Green
tea and ancient wellness ingredients (jujube, ginseng,…)

Presentation

The company has managed to bridge the ancient Chinese traditional wellness with a modern
“carrier” brand. All the major ingredients in their hot & iced range of drinks come from the same
ancient wellness source i.e. the “Bencao gangmu”, a Chinese medical book of ancient health and
wellness traditions. This enables them to craft authentic & connected messages about the drink’s
virtues. It also gives access to a huge range of fruit & botanicals for blending into the drinks -
some already familiar like mandarin and some that are excitingly new to us like the super fruit,
“Jujube” [a Chinese red date (hong zao 红枣) known as the “King of Vitamin C”, packing a
powerful boost for the body especially in the production of collagen so better than what many
“beauty drinks” offer….and the subject of a traditional saying “3 jujubes a day keep the doctor
away”.
Datamonitor cites Tg Green Teas as one of only a handful of new drinks globally that meet the
evolving needs of consumers i.e. health demands for both added and in-built natural health
benefits.(Consumer and Consumer and Innovation Trends in RTD Tea” -March 2015).

Leadership team

  • Sophia NADUR, CEO co-founder
neuro-sys

7. Neuro-sys

Main activity

Neuro-Sys is specialized into the discovery, efficacy and mode of action assessments of
ingredients, extracts and molecules focusing on neurodegenerative diseases.

Presentation

Neuro-Sys is a privately owned start-up CRO/biotechnology company based in France.
Neuro-Sys offers a wide range of in vitro (to in vivo with partners) services via state of the art
screening assays through its proprietary pharmacological platforms.
Neuro-Sys’ goal is to provide clients with the highest-quality preclinical efficacy and mode of
action contract services for CNS diseases (mainly ALZHEIMER’S, PARKINSON’S, ALS).
The platforms owned and developed by Neuro-Sys are designed by nature to accept all kind of
entities from the molecule to a natural product itself (plants…) by realizing all the steps from the
natural product green-extraction to the pharmacological/analytical profile.
The company and its team are dedicated to offer solutions to the customers from academia and
industry for their research and development projects and needs.
On the Drug Discovery side, Neuro-Sys develops its proper programs to discover news active
compounds coming from South-East Asia medicinal plants. Brand new patented compounds with
a proven activity are then proposed to the industry.
This activity relies on its strategic and exclusive partnership with the IDVP: Institut de
Développement Vietnam Pacifique (Vietnam Pacific Development Institution). Neuro-Sys then
benefits from a privileged access to the Vietnamese medicinal plants pharmacopeia with a
neuroprotective effect.

Leadership team

  • Yann JAUDOUIN, CEO
3F bio

8. 3F Bio

Main activity

Integrated fermentation of protein

Presentation

3f bio’s vision is to address global needs for sustainable protein, and the business objective is to
commercialise a novel and patented technology for large-scale integrated production of Food,
Fuel and Feed. 3f bio’s technology combines an established process for manufacturing
mycoprotein as a zero-waste integrated process within a biorefinery. This has a proven market
and is relevant and competitive in the $850bn global market for animal protein.
Mycoprotein is the protein component in Quorn™, which is the branded global market leader in
the expanding $3.8bn meat-free market sector. Mycoprotein was originally developed by RHM
and ICI in the 1970’s and was the ‘victor’ in the search for a high-quality meat alternative. To
date, it has solely been commercialised under the TM Quorn, due to a combined barrier to entry
of high capital costs, and a patent which expired in 2010. The 3f process will revolutionize the
production and capital economics whilst delivering an exceptional sustainability profile. The
standard mycoprotein fermentation process produces excess sugar, waste protein and effluent,
but the novel process of integrating this within a biorefinery transforms the cost of mycoprotein
by utilising lower feedstock and reduced energy costs. This produces lower cost alongside an
exceptional sustainability and carbon intensity profile.
3f's business model is to develop this with globally recognised partners with expertise and
interest technology implementation, biorefining and a global food/ingredient partner and
discussions are advanced in each area. 3fbio’s technology will halve the cost of mycoprotein
production making it substantially cheaper than the lowest cost meats, moving it from being a
premium vegetarian option to a mainstream low cost source of sustainable protein for global
populations.

Leadership team

  • Jim LAIRD, CEO
ALKION BIO

9. Alkion Bio Innovations

Main activity

Alkion BI is a greentech startup specialized in the development & production of innovative natural non-GMO active ingredients for human & animal nutrition, agronomy and non-cosmetic flagrance. 

Presentation

Alkaburst+; our non-GMO technological platform, enhances the plants supercapacities:

  • develop & produce hyperactive extracts with "hyper" yields (800 times what is obtained on soil today and 2000 times tomorrow)
  • sleepy genes expression
  • new complex molecules produced
  • cryoperservation of plant cells for standardization

In affordable & sustainable conditions:

  • limited cost of production
  • non-GMO, non-pesticides, non-herbicides, no-heavy metals
  • non-destructive technology for the protection of the Biodiversity (Nagoya)
  • sustainable technology with low energy/water consumption
  • production independent of external conditions

Leadership team

  • Franck PRADIER, Managing Director
Olygose

10. Olygose

Main activity

Olygose develops, produces and markets a range of innovative patented ingredients extracted
from vegetable raw materials, including legumes.

Presentation

Olygose has developed and patented a plant-based alternative to beta-GOS by extracting pea
serum alpha-galacto-oligosaccharides, a co-product of pea protein production (whose volumes
are also increasing globally) for the infant milk formula market.
Alpha-GOS is marketed under the P-GOS brand have a prebiotic profile similar to those of beta-
GOS. They are an alternative to the beta-GOS in formulas for specific populations or for plantbased
formulas.
The objective of producers of infant milk is to propose alternatives that are as close as possible
to breast milk in order to ensure the adequate development of infants. Beyond the basic
requirements of nutritional composition, infant milk producers have the option of adding
additional ingredients if they are safe and have a nutritional benefit for infants and young children.
So for more than 20 years many formulas on the market have been enriched with prebiotic
fibers, using them to mimic the effects of oligosaccharides naturally present in human milk.
Beta-Galacto-oligosaccharides (GOS), produced from lactose, are now considered the reference
prebiotic in infant formulas due to their effects on the intestinal microbiota as well as on several
other physiological functions such as intestinal transit or immunity. The volume of the GOS
market is constantly increasing (forecast CAGR 14% between 2014 and 2020) and will reach a
volume of about 80 000 tons by 2020.
However, due to their dairy origin, beta-GOS is not currently used in specific formulas
(ADDFMS) for the management of lactose intolerance or cow's milk protein allergy.

Leadership team

  • Eric CHAPPUIS, Senior Nutrition Science Manager
Agroparc

Presans

Naturex